Melotti A et al., 2014-10: A Geneva group reports ivermectin blocks WNT-TCF signalling and inhibits growth of TCF-dependent xenografts, and flags selamectin as more potent.
In vivo, Ivermectin selectively inhibits TCF-dependent, but not TCF-independent, xenograft growth without obvious side effects.
1263
Melotti A et al., 2014-10: A Geneva group reports ivermectin blocks WNT-TCF signalling and inhibits growth of TCF-dependent xenografts, and flags selamectin as more potent. Study type: lab.
